Lantern Pharma Reports Second Quarter 2021 Financial Results and Operational Highlights

Go back to Lantern Pharma Reports Second Quarter 2021 Financial Results and Operational Highlights
(NASDAQ: LTRN) Delayed: 2.34 +0.05 (2.18%)
Previous Close $2.29    52 Week High
Open $2.32    52 Week Low
Day High $2.41    P/E N/A 
Day Low $2.13    EPS
Volume 185,082